FDA Inspection 1252468 — Gulf Coast Regional Blood Center at Cypress Fairbanks
The FDA completed an inspection of Gulf Coast Regional Blood Center at Cypress Fairbanks on October 11, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 11, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)